Abbott Laboratories
ABT
Revenue
10.64B
▲258.00M▲2.49%
3 Months ChangeAssets
74.36B
▲1.34B▲1.83%
3 Months ChangeLiabilities
34.56B
▲861.00M▲2.55%
3 Months ChangeFree Cash Flow
627.00M
▼-136.00M▼-17.82%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 10-Q
ID: 0001628280-24-044602
2024-10-16
Form 8-K
ID: 0001628280-24-042893
2024-07-31
Form 10-Q
ID: 0001628280-24-033740
2024-07-18
Form 8-K
ID: 0001628280-24-032182
2024-05-02
Form 10-Q
ID: 0001628280-24-020011
2024-05-01
Form 8-K
ID: 0001104659-24-055724
2024-04-29
Form 8-K
ID: 0001104659-24-054016
2024-04-17
Form 8-K
ID: 0001628280-24-016497
2024-01-29
Form 8-K
ID: 0001104659-24-007725
2024-01-24
Form 8-K
ID: 0001628280-24-002009